Literature DB >> 30573349

Safety of elective percutaneous peripheral revascularization in outpatients: A 10-year single-center experience.

S Malekzadeh1, T Rolf1, F Doenz1, A Chouiter1, A-M Jouannic1, S D Qanadli2.   

Abstract

PURPOSE: To evaluate the safety and feasibility of peripheral percutaneous endovascular procedures in a large group of outpatients with peripheral arterial disease (PAD).
MATERIALS AND METHODS: We retrospectively evaluated all consecutive patients who underwent peripheral transluminal angioplasty (PTA) for PAD of the lower extremities as "Out-Patient Admission Protocol" (OPAP) from January 2005 until December 2015. A total of 498 consecutive patients (305 men and 193 women) with mean age of 66±10 (SD) years (range: 37-90 years) were evaluated. By protocol, patients were expected to be discharged 6hours after the procedure. Clinical profile, procedure details and technical success were reviewed. Complications, conversion rate, readmission rate and long-term follow-up were evaluated.
RESULTS: Ninety one percent of patients (454/498) suffered from claudication. Unilateral femoral access was performed in 75.4% (493/654) of procedures with a 6-French sheath in 80.7% (528/654) of procedures. Balloon PTA alone was performed in 17.3% (148/857) and stent placement in 82.7% (709/857) of treated segments. Technical success of lesion treatment was 98.2% (857/873). Closure devices were used in 55.4% (362/654) of procedures. Conversion and readmission rates were 1.8% (12/654) and 0.6% (4/654), respectively. Long-term follow-up was obtained in 386 target lesions, 5-year restenosis of lesion was 20.5% (79/386).
CONCLUSION: As designed, the OPAP was feasible, safe and effective with very low conversion and complications rates. These results strongly support a larger use of such approaches as routine practice.
Copyright © 2018. Published by Elsevier Masson SAS.

Entities:  

Keywords:  Interventional radiology; Outpatients; Percutaneous angioplasty; Peripheral arterial disease

Mesh:

Year:  2018        PMID: 30573349     DOI: 10.1016/j.diii.2018.11.009

Source DB:  PubMed          Journal:  Diagn Interv Imaging        ISSN: 2211-5684            Impact factor:   4.026


  2 in total

1.  Virtually Augmented Self-Hypnosis applied to endovascular interventions (VA-HYPO): Randomized Controlled Trial Protocol.

Authors:  Salah D Qanadli; Louis Gudmundsson; Giuseppe Gullo; Alexandre Ponti; Sarah Saltiel; Anne-Marie Jouannic; Mohamed Faouzi; David C Rotzinger
Journal:  PLoS One       Date:  2022-02-23       Impact factor: 3.240

2.  Research in Vascular Medicine: Where We Are and Where We Are Going.

Authors:  Salah D Qanadli
Journal:  Front Cardiovasc Med       Date:  2020-03-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.